This investment of Bristol Myers Squibbin Karuna is big and betting big on this drug KarXT. It appears Neuland labs will be at advantage, however the quantum of benefit and the timelines are not yet out,
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
